Target intelligence / Profile preview

T-cell receptor beta variable 9 (TRBV9)

Target
TRBV9
Molecular classification
Receptor, Immunoglobulin superfamily, T cell receptor component
01

Overview

T-cell receptor beta variable 9 (TRBV9) is a protein segment that constitutes the variable domain of the beta chain of the T cell receptor (TCR) complex. The TCR, particularly the alpha-beta heterodimer, is a key component of the adaptive immune system, responsible for recognizing and binding to antigenic peptides presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells. The TRBV9 gene encodes the variable region of the TCR beta chain, contributing to the diversity of the T cell repertoire through V(D)J recombination in the thymus. This diversity allows effective immune surveillance against a wide array of pathogens. Upon recognition of peptide-MHC by the TCR, signal transduction is mediated through associated CD3 molecules, initiating T cell activation, proliferation, and effector functions. TRBV9 and other TCR Vβ chains play critical roles in antigen specificity, shaping immune responses, and have clinical importance in disease contexts such as infection, cancer, and autoimmunity[1][2][7].

Other names
TCRBV9T cell receptor beta variable 9TVB9
02

Mechanism of action

Recognition of peptide-MHC complexes leading to T cell activation via CD3 signaling

03

Biological functions

Antigen recognitionSignal transductionImmune response
04

Disease associations

Cancer (some clones may be involved in lymphoproliferative disorders or T cell malignancies)Infection (implicated in the immune response to pathogens)Inflammation (involved in autoimmune and inflammatory diseases)
05

Safety considerations

Potential for autoimmunity if self-antigen recognition occursRisk of cytokine release syndrome if broadly activated therapeutically (as applies to TCR targeting therapies in general)
06

Biomarkers

TCRVβ9 usage or clonotypes are studied as biomarkers in immune repertoire analyses and may be monitored for clonal expansion in certain diseases

Beyond the preview

Go deeper on T-cell receptor beta variable 9 (TRBV9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-cell receptor beta variable 9 (TRBV9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call